ABZYME RESEARCH FOUNDATION
Abzyme Research Foundation offers a new model of HIV research, advocacy, and funding. Our mission is to advance a promising HIV vaccine into human trials, with the larger goal of creating a safe, affordable, widely accessible vaccine to eradicate the spread of HIV globally.
ARF was founded to present a new model of HIV research advocacy and funding. We exist solely to advance an innovative therapeutic HIV vaccine candidate into human trials. We know a vaccine is essential to eradicate the spread of HIV/AIDS. Based on strong research, we believe abzymes are the key.
Our non-profit vaccine development model consists of synergistically working with for-profit and governmental entities to establish vaccine efficacy and safety. Covalent Bioscience, our for-profit start-up partner, has committed to the principle of ensuring equitable access to the E-Vaccine for economically disadvantaged segments of society. About 60% of infected humans currently do not have access to HIV therapies because of cost.
In 2016, thanks to the generous support of private donors underwriting our campaign, 100% of your donation will go directly to supporting this HIV/AIDS cure research. Here is the breakdown.